Bipolar is one of the UK’s commonest long-term conditions with almost as many people living with bipolar as cancer. 1.3 million people in the UK have bipolar, that is one in fifty people. It takes an average 9.5 years to get a correct diagnosis of bipolar disorder and there is a misdiagnosis an average of 3.5 times. 

In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks with Professor Carolyn Chew-Graham, a GP in Manchester with a research interest in mental health and Professor of General Practice Research at Keele University, about the assessment and management of bipolar disorder.

In this 15 minute podcast, Dr Michael Mulholland, RCGP Honorary Secretary, talks to Dr Joy Shacklock, GP and RCGP Clinical Policy Representative for Safeguarding, about the new RCGP safeguarding standards. Joy explains the new document and the drivers behind the updates, as well as the supporting resources and how they can be used. In particular, she highlights the new all-age safeguarding toolkit and how to get the best out of it, along with pointers on safeguarding training and updated revalidation requirements. 

This podcast was produced by RCGP Learning. Editorial and content decisions were made solely by the RCGP. 

An estimated 10 million people (6 million women, 4 million men) in the UK have osteoarthritis, with an estimated 5.4 million people affected osteoarthritis in the knee and 3.2 million in the hip. An estimated 350,000 people are diagnosed with osteoarthritis each year with a median age of symptom onset of 55 years.

In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks with Dr Louise Warburton, a GP with a special interest in musculoskeletal care and rheumatology, Honorary Senior Lecturer at Keele University and Co-president of the Primary Care Rheumatology and Musculoskeletal Medicine Society, about osteoarthritis including risk factors, presentation, clinical history, examination, diagnosis and treatment/self management.  

Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.

Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.

A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors). 

In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks with Dr Nicola Weaver, a GP and Clinical Cancer Lead in Southwark, Southeast London about familial breast cancer including the recent changes to the NICE guideline. 

Both the combined and progestin-only pills are highly effective with perfect use, with a failure rate of less than 1%. However, the failure rate with “typical use” is 9%, which accounts for inconsistent or incorrect use.

In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks to Dr Toni Hazell, a GP with an interest in women's health and the RCGP Deputy Medical Director for eLearning about the types of combined oral contraception, risk assessment tools e.g. UKMEC, contraindications, individualising pill taking regimes, missed pill rules and common myths. 

In this podcast Dr Emma Nash talks to Dr Pranav Sharma about gender bias in pain. They discuss what gender bias in pain is, and what evidence there is that it exists. Dr Sharma goes on to explain the possible reasons why it came about and what we can do to address it in our own practice.

Aspergillus is a mould which is found in soil, organic matter and sometimes in air conditioning units. Its size means that it can easily be breathed in and can cause respiratory disease, as well as pathology in other body systems including the skin and the eye. This podcast focuses on allergic bronchopulmonary aspergillosis, a condition which is present in 13% of adults and up to 50% of children with severe asthma. The podcast discusses when to suspect aspergillosis and the investigations which might be useful in primary care, as well as outlining an approach to the patient who comes to see you with concerns about mould in their home. 

Health inequalities, the differences in health levels and outcomes between individuals and groups of individuals, are an issue of fundamental importance for general practice. For the RCGP's chair, Professor Kamila Hawthorne, tackling health inequalities is an integral part of general practice: because GPs are expert medical generalists at the heart of their community, general practice has a pivotal role to play in combatting the causes of health inequalities and dealing with their effects. In this podcast, Professor Margaret Ikpoh, GP in Hull and vice-chair for professional development and standards discusses the impact of health inequalities on deprived communities with Professor Dom Patterson, GP in Doncaster, chair of the RCGP’s health inequalities group and founder and CEO of Fairhealth. They highlight solutions that can be implemented on individual, practice and ICB level.

This podcast was produced by RCGP Learning. Editorial and content decisions were made solely by the RCGP. 

More than 1 in 4 women aged 16 to 24 years report having self-harmed at some point, compared to around 1 in 10 men of the same age. Research suggests as many as two thirds of people who self-harm will have seen their GP in the month before or after an episode of self-harm. In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks to Professor Carolyn Chew-Graham, a Professor of General Practice Research at Keele University and a GP in Manchester, about assessment, management and prevention of self-harm.

Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms suggestive of colorectal cancer to the right diagnostic pathway. In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks to Dr Kevin Barrett, a GP in Hertfordshire with a special interest in gastroenterology, about faecal immunochemical testing in patients with signs or symptoms of suspected colorectal cancer (CRC)